The DNA methylation indicator of NR6A1 was found to be prognostic in a validation study of potential prognostic DNA methylation biomarkers in patients with acute myeloid leukemia (Šestáková et al., 2022). This evidence concerns the gene NR6A1 and acute myeloid leukemia.